NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NuCana plc
Eastern Cooperative Oncology Group
Georgetown University
King Faisal Specialist Hospital & Research Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Case Comprehensive Cancer Center